Independent precision-oncology interpretation for patients, families, and care teams seeking clearer insight from genomic, molecular, pathology, and treatment information.
Monarch Precision Oncology was created to help people better understand the scientific information behind their cancer diagnosis and treatment options. Many patients receive genomic reports, pathology findings, imaging summaries, or lists of possible therapies without a clear explanation of what those results may mean.
MPO provides independent, evidence-based interpretation of molecular and clinical information. Our role is to clarify the biology of the cancer, explain relevant biomarkers, identify questions to discuss with the treating oncologist, and highlight clinical trials or treatment concepts that may be worth reviewing with the medical team. MPO does not replace the treating physician; it helps patients and families prepare for more informed conversations.
MPO focuses on scientific interpretation, evidence review, and practical preparation for oncology discussions.
We review genomic, biomarker, pathology, and molecular-testing reports and explain their potential clinical relevance in clear language.
We summarize evidence-based treatment concepts that may be relevant to the cancer type, stage, biomarkers, and prior therapies.
We prepare focused, practical questions patients can bring to their oncologist to support clearer treatment discussions.
We identify clinical trials or investigational strategies that appear biologically relevant and help patients understand what eligibility questions to ask.
A focused review process built around your reports and clinical questions.
Provide pathology reports, molecular testing, imaging summaries, treatment history, and your main questions.
MPO evaluates biomarkers, pathways, resistance patterns, and evidence relevant to the available information.
You receive an organized explanation of key findings, clinical-trial considerations, and discussion points.
Use the summary to support a more focused conversation with your treating medical team.
These examples show the types of scientific questions that can be addressed during a molecular review.
What does this mutation, amplification, fusion, or biomarker result mean in the context of my cancer type and treatment history?
Which treatment concepts are supported by available evidence, and which questions should I discuss with my oncologist?
Are there trials that appear biologically relevant to my cancer profile, and what eligibility details should be checked?
MPO can help translate complex findings into clearer questions for your oncology team.
Request a Molecular ReviewWhether you have a genomic report, pathology result, imaging summary, or treatment question, MPO can help organize the information into a clearer scientific review. Every inquiry is treated confidentially.